We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
+4.87%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$106B
AUM Growth
+$3.62B
(+3.5%)
Cap. Flow
-$1.47B
Cap. Flow
% of AUM
-1.39%
Top 10 Holdings %
Top 10 Hldgs %
14.33%
Holding
3,812
New
177
Increased
783
Reduced
2,146
Closed
145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$743M |
| 2 |
APC
Anadarko Petroleum
APC
|
+$215M |
| 3 |
Chevron
CVX
|
+$189M |
| 4 |
XEC
CIMAREX ENERGY CO
XEC
|
+$161M |
| 5 |
Meta Platforms (Facebook)
META
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$281M |
| 2 |
Amazon
AMZN
|
+$228M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$219M |
| 4 |
Eli Lilly
LLY
|
+$212M |
| 5 |
RTX Corp
RTX
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.44% |
| 2 | Healthcare | 15.11% |
| 3 | Industrials | 11.28% |
| 4 | Energy | 10.95% |
| 5 | Technology | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Lumen
LUMN
$6.48B
| $237K | ﹤0.01% |
6,556
-110
| -2% | -$3.95K |
|
2502
Utah Medical Products
UTMD
$214M
| $237K | ﹤0.01% |
4,609
+2,206
| +92% | +$113K |
|
|
ASPX
2503
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $237K | ﹤0.01% |
10,626
+8,370
| +371% | +$183K |
|
|
HTO
2504
H2O America
HTO
$2.66B
| $236K | ﹤0.01% |
8,673
-1,418
| -14% | -$38.8K |
|
2505
Central Garden & Pet Co Class A
CENTA
$2.44B
| $235K | ﹤0.01% |
31,868
-4,401
| -12% | -$29.5K |
|
2506
Greif
GEF
$4.56B
| $235K | ﹤0.01% |
4,302
| – | – |
|
|
LBAI
2507
DELISTED
Lakeland Bancorp Inc
LBAI
| $235K | ﹤0.01% |
21,752
-3,595
| -14% | -$37.3K |
|
|
GLRI
2508
DELISTED
GLORI ENERGY INC COMMON STOCK
GLRI
| $235K | ﹤0.01% |
+21,659
| New | +$200K |
|
|
BRCM
2509
DELISTED
BROADCOM CORP CL-A
BRCM
| $235K | ﹤0.01% |
6,340
-37
| -0.6% | -$1.21K |
|
|
ANV
2510
DELISTED
Allied Nevada Gold Corp
ANV
| $235K | ﹤0.01% |
62,629
-9,032
| -13% | -$31.3K |
|
|
IIP
2511
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
| $235K | ﹤0.01% |
33,382
-3,758
| -10% | -$26.5K |
|
|
AMWD
2512
DELISTED
American Woodmark
AMWD
| $233K | ﹤0.01% |
7,309
-169
| -2% | -$5.16K |
|
2513
BancFirst
BANF
$3.92B
| $233K | ﹤0.01% |
7,528
-1,730
| -19% | -$51.3K |
|
2514
Marchex
MCHX
$79.7M
| $233K | ﹤0.01% |
19,344
+3,446
| +22% | +$36.3K |
|
|
SREV
2515
DELISTED
ServiceSource International, Inc.
SREV
| $233K | ﹤0.01% |
40,123
-1,170
| -3% | -$6.49K |
|
|
SNMX
2516
DELISTED
Senomyx, Inc.
SNMX
| $233K | ﹤0.01% |
26,920
+17,961
| +200% | +$150K |
|
|
ZEP
2517
DELISTED
ZEP INC COM STK (DE)
ZEP
| $233K | ﹤0.01% |
13,175
-2,065
| -14% | -$36.3K |
|
2518
Lexicon Pharmaceuticals
LXRX
$1.04B
| $232K | ﹤0.01% |
20,619
-3,028
| -13% | -$32.5K |
|
2519
Douglas Dynamics
PLOW
$1.05B
| $232K | ﹤0.01% |
13,140
-13,676
| -51% | -$237K |
|
|
ECOM
2520
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $232K | ﹤0.01% |
8,787
-297,410
| -97% | -$7.55M |
|
|
DNDN
2521
DELISTED
DENDREON CORPORATION
DNDN
| $232K | ﹤0.01% |
100,906
-1,147,945
| -92% | -$2.69M |
|
|
GOOD
2522
Gladstone Commercial Corp
GOOD
$631M
| $231K | ﹤0.01% |
12,940
-2,423
| -16% | -$42.5K |
|
2523
Booz Allen Hamilton
BAH
$8.64B
| $230K | ﹤0.01% |
10,829
+1,408
| +15% | +$31.8K |
|
|
LIOX
2524
DELISTED
Lionbridge Technologies
LIOX
| $230K | ﹤0.01% |
38,673
-821
| -2% | -$4.81K |
|
|
JRN
2525
DELISTED
JOURNAL COMMUNICATIONS INC CL-A
JRN
| $230K | ﹤0.01% |
25,923
-3,981
| -13% | -$32.9K |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q2 2014 Portfolio in Review
As of Q2 2014, BlackRock Advisors held 3,812 positions worth $106B, up 3.5% from $102B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BlackRock Advisors's Q2 2014 filing shows 177 new, 783 increased, 2,146 reduced and 145 closed positions. Its largest new stake was iShares US Financials ETF: 3,120,594 shares worth $130M. The largest sale was Pfizer, an estimated $281M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Industrials.
- BlackRock Advisors's largest Q2 2014 buy was iShares US Financials ETF: 3,120,594 shares worth $130M.
- BlackRock Advisors added most to Apple in Q2 2014, an estimated $743M increase.
- BlackRock Advisors's biggest Q2 2014 reduction was Pfizer, cutting an estimated $281M.
- BlackRock Advisors fully exited PPL CORP CORP UITS CONSISTING OF PUR CONTRACT JR SUB NTS in Q2 2014, selling an estimated $40.9M.
- BlackRock Advisors's ten largest holdings make up 14% of its $106B portfolio in Q2 2014.
- BlackRock Advisors opened 177 new positions and closed 145 in Q2 2014.
- BlackRock Advisors's portfolio value rose 3.5% quarter-over-quarter to $106B.
Based on BlackRock Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.